Slow Bull
The market, slowly. SATURDAY, 26 SEPTEMBER 2026

Pyxis Oncology, Inc.

PYXS Nasdaq SEC CIK 1782223
Follow Pyxis Oncology Weekly email: filings, results, news

Financials

Reported figures only · latest: Q2 2026 USD · US GAAP
Net income −$25.3M −38.1% vs same quarter last year
EPS, diluted −$0.40 −33.3% vs same quarter last year
Operating cash flow −$18.2M −5.5% vs same quarter last year
Operating income −$26M −31.6% vs same quarter last year
Revenue by quarter
$0
$0
$2.8M
$0
$11M
Q3 24 Q4 24 Q2 25 Q3 25 Q4 25

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income7 fiscal years
−$150M−$100M−$50M$0FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearNet income
FY25−$79.6M
FY24−$77.3M
FY23−$73.8M
FY22−$120.7M
FY21−$76M
FY20−$12.8M
FY19-
Free cash flowOperating cash flow minus capital expenditure
−$100M−$75M−$50M−$25M$0FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearFree cash flow
FY25−$63.5M
FY24−$57.9M
FY23−$77.4M
FY22−$95.7M
FY21−$35.9M
FY20−$11.6M
FY19-

News

No stories filed under Pyxis Oncology yet - coverage appears here as the news feed clusters it.